Document is current

Article History

Received: 3 April 2026

Accepted: 27 May 2026

First Online: 3 June 2026

Declarations

:

: The study was evaluated and approved by the Research Ethics Committee at the San Carlos Clinical Hospital of Madrid, Spain (Trial registration code CEIC 19/216-R_M_BNI) and the Agencia Española del Medicamento y Productos Sanitarios (AEMPS: Spanish Agency of Drugs and Sanitary Products, EUDRACT number 2019–000,736). This study was performed in line with the principles of the Declaration of Helsinki.

: Informed consent was obtained from all individual participants included in the study.

: During the preparation of this work, the author(s) used ChatGPT (OpenAI) to improve the readability, clarity, and structure of the manuscript. After using this tool, the author(s) reviewed and edited the content as needed and take full responsibility for the content of the publication.

: The authors declare no competing interests.